Veritone (VERI) 10-Q 15 Nov 21 2021 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2021	Nov. 12, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Trading Symbol	VERI
Entity Registrant Name	Veritone, Inc.
Entity Central Index Key	0001615165
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity File Number	001-38093
Entity Tax Identification Number	47-1161641
Entity Address, Address Line One	2420 17th St.
Entity Address, Address Line Two	Office 3002
Entity Address, City or Town	Denver
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80202
City Area Code	888
Local Phone Number	507-1737
Entity Common Stock, Shares Outstanding		34,876,616
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	DE
Document Quarterly Report	true
Document Transition Report	false
Title of 12(b) Security	Common Stock, par value $0.001 per share
Security Exchange Name	NASDAQ

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
ASSETS
Cash and cash equivalents	$ 72,645	$ 114,817
Accounts receivable, net	57,903	16,666
Expenditures billable to clients	25,236	18,365
Prepaid expenses and other current assets	10,683	6,719
Total current assets	166,467	156,567
Property, equipment and improvements, net	1,178	2,354
Intangible assets, net	92,904	10,744
Goodwill	27,999	6,904
Long-term restricted cash	855	855
Other assets	1,793	230
Total assets	291,196	177,654
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable	33,102	15,632
Accrued media payments	75,171	55,874
Client advances	8,402	6,496
Contingent consideration, current	19,307
Other accrued liabilities	37,131	10,246
Total current liabilities	173,113	88,248
Contingent consideration, non-current	8,533
Other non-current liabilities	1,884	1,196
Total liabilities	183,530	89,444
Commitments and contingencies (Note 8)
Stockholders' equity
Common stock, par value $0.001 per share; 75,000,000 shares authorized; 34,857,163 and 31,799,354 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively	35	32
Additional paid-in capital	442,870	368,477
Accumulated deficit	(335,091)	(280,365)
Accumulated other comprehensive (loss) income	(148)	66
Total stockholders' equity	107,666	88,210
Total liabilities and stockholders' equity	$ 291,196	$ 177,654

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Statement Of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	34,857,163	31,799,354
Common stock, shares outstanding	34,857,163	31,799,354

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Revenue	$ 22,655	$ 15,718	$ 60,156	$ 40,890
Operating expenses:
Cost of revenue	5,808	4,553	15,862	11,566
Sales and marketing	5,906	5,255	17,586	15,116
Research and development	5,254	3,587	14,860	10,673
General and administrative	15,037	11,950	62,225	34,836
Amortization	1,683	1,346	3,840	4,040
Total operating expenses	33,688	26,691	114,373	76,231
Loss from operations	(11,033)	(10,973)	(54,217)	(35,341)
Other expense, net	(15)	(4)	(37)	(108)
Loss before provision for income taxes	(11,048)	(10,977)	(54,254)	(35,449)
Provision for income taxes	396	36	472	41
Net loss	$ (11,444)	$ (11,013)	$ (54,726)	$ (35,490)
Net loss per share:
Basic and diluted	$ (0.34)	$ (0.40)	$ (1.67)	$ (1.31)
Weighted average shares outstanding:
Basic and diluted	33,332,668	27,593,315	32,752,939	27,162,880
Comprehensive loss:
Net loss	$ (11,444)	$ (11,013)	$ (54,726)	$ (35,490)
Foreign currency translation gain, net of income taxes		6	7	11
Total comprehensive loss	$ (11,444)	$ (11,007)	$ (54,719)	$ (35,479)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income [Member]
Beginning balance at Dec. 31, 2019	$ 47,411	$ 26	$ 279,828	$ (232,489)	$ 46
Beginning balance, shares at Dec. 31, 2019		25,670,737
Common stock offerings, net	5,996	$ 2	5,994
Common stock offerings, net, shares		1,491,317
Common stock issued under employee stock plans, net	356		356
Common stock issued under employee stock plans, net, shares		297,490
Release of Machine Box holdback consideration, shares		105,898
Stock-based compensation expense	13,735		13,735
Exercise of warrants	2,100	$ 2,100	2,100
Exercise of warrants, shares		154,311
Issuance of warrants	308		308
Net loss	(35,490)			(35,490)
Other comprehensive gain (loss)	11				11
Ending balance at Sep. 30, 2020	34,427	$ 28	302,321	(267,979)	57
Ending balance, shares at Sep. 30, 2020		27,719,753
Beginning balance at Dec. 31, 2019	47,411	$ 26	279,828	(232,489)	46
Beginning balance, shares at Dec. 31, 2019		25,670,737
Net loss	(47,876)
Ending balance at Dec. 31, 2020	88,210	$ 32	368,477	(280,365)	66
Ending balance, shares at Dec. 31, 2020		31,799,354
Beginning balance at Jun. 30, 2020	40,080	$ 28	296,967	(256,966)	51
Beginning balance, shares at Jun. 30, 2020		27,516,307
Common stock offerings, net	(10)		(10)
Common stock issued under employee stock plans, net	216		216
Common stock issued under employee stock plans, net, shares		97,548
Release of Machine Box holdback consideration, shares		105,898
Stock-based compensation expense	5,148		5,148
Net loss	(11,013)			(11,013)
Other comprehensive gain (loss)	6				6
Ending balance at Sep. 30, 2020	34,427	$ 28	302,321	(267,979)	57
Ending balance, shares at Sep. 30, 2020		27,719,753
Beginning balance at Dec. 31, 2020	88,210	$ 32	368,477	(280,365)	66
Beginning balance, shares at Dec. 31, 2020		31,799,354
Common stock issued under employee stock plans, net	7,126	$ 1	7,125
Common stock issued under employee stock plans, net, shares		1,084,941
Common stock issued for acquisition	31,500	$ 2	31,498
Common stock issued for acquisitions, shares		1,704,822
Stock-based compensation expense	33,241		33,241
Exercise of warrants	2,279	$ 2,279	2,279
Exercise of warrants, shares		252,218
Net loss	(54,726)			(54,726)
Other comprehensive gain (loss)	(214)				(214)
Ending balance at Sep. 30, 2021	107,666	$ 35	442,870	(335,091)	(148)
Ending balance, shares at Sep. 30, 2021		34,857,163
Common stock issued for services	250		250
Common stock issued for services, shares		15,828
Beginning balance at Jun. 30, 2021	80,227	$ 33	403,768	(323,647)	73
Beginning balance, shares at Jun. 30, 2021		32,870,767
Common stock issued under employee stock plans, net	2,332		2,332
Common stock issued under employee stock plans, net, shares		281,574
Common stock issued for acquisition	31,500	$ 2	31,498
Common stock issued for acquisitions, shares		1,704,822
Stock-based compensation expense	5,272		5,272
Net loss	(11,444)			(11,444)
Other comprehensive gain (loss)	(221)				(221)
Ending balance at Sep. 30, 2021	$ 107,666	$ 35	$ 442,870	$ (335,091)	$ (148)
Ending balance, shares at Sep. 30, 2021		34,857,163

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Cash flows from operating activities:
Net loss			$ (54,726)	$ (35,490)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization			4,189	4,816
Loss on disposal of fixed assets			1,894	102
Provision for doubtful accounts			14	291
Loss on sublease			1,211
Change in fair value of warrant liability				200
Change in fair value of contingent consideration			256
Stock-based compensation expense	$ 5,272	$ 5,111	33,491	13,698
Changes in assets and liabilities:
Accounts receivable			(19,907)	3,535
Expenditures billable to clients			(6,871)	(9,822)
Prepaid expenses and other assets			5,014	(131)
Accounts payable			4,288	4,254
Accrued media payments			19,297	14,562
Client advances			1,906	4,687
Other accrued liabilities			7,016	708
Other liabilities			(600)	(128)
Net cash (used in) provided by operating activities			(3,528)	1,282
Cash flows from investing activities:
Proceeds from the sale of equipment				56
Capital expenditures			(448)	(61)
Acquisitions, net of cash acquired			(47,602)
Net cash used in investing activities			(48,050)	(5)
Cash flows from financing activities:
Proceeds from issuances of stock under employee stock plans, net			7,127	356
Proceeds from the exercise of warrants			2,279	2,100
Proceeds from common stock offerings, net				6,517
Proceeds from loan				6,491
Repayment of loan				(6,491)
Net cash provided by financing activities			9,406	8,973
Net (decrease) increase in cash and cash equivalents and restricted cash			(42,172)	10,250
Cash and cash equivalents and restricted cash, beginning of period			115,672	44,920	$ 44,920
Cash and cash equivalents and restricted cash, end of period	$ 73,500	$ 55,170	$ 73,500	$ 55,170	$ 115,672

Description of Business

Description of Business	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Description of Business	NOTE 1. DESCRIPTION OF BUSINESS Description of Business Veritone, Inc., a Delaware corporation (“Veritone”) (together with its wholly owned subsidiaries, collectively, the “Company”), is a provider of artificial intelligence (“AI”) computing solutions. The Company’s proprietary AI operating system, aiWARE TM The Company also offers cloud-native digital content management solutions and content licensing services, primarily to customers in the media and entertainment market. These offerings leverage the Company’s aiWARE technologies, providing customers with unique capabilities to enrich and drive expanded revenue opportunities from their content. In addition, the Company operates a full-service advertising agency that leverages the Company’s aiWARE technologies to provide differentiated Managed Services to its clients. The Company’s advertising services include media planning and strategy, advertisement buying and placement, campaign messaging, clearance verification and attribution, and custom analytics, specializing in host-endorsed and influencer advertising across primarily radio, podcasting, streaming audio, social media and other digital media channels. The Company’s advertising services also include its VeriAds TM On September 14, 2021, the Company acquired PandoLogic Ltd., a leading provider of intelligent hiring solutions (“PandoLogic”), a company incorporated under the laws of the state of Israel (“PandoLogic”), as discussed in more detail in Note 3. PandoLogic’s platform, pandoIQ, is an AI-enabled recruitment platform.

Presentation and Summary of Sig

Presentation and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Presentation and Summary of Significant Accounting Policies	NOTE 2. PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Preparation The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial statements and the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. Such unaudited condensed consolidated financial statements and accompanying notes are based on the representations of the Company’s management, who is responsible for their integrity and objectivity. The information included in this Form 10-Q should be read in conjunction with the information included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 5, 2021. Interim results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results the Company will have for the full year ending December 31, 2021. The accompanying condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which are normal, recurring and necessary to fairly state the Company’s financial position, results of operations and cash flows. All significant intercompany transactions have been eliminated in consolidation. The financial data and the other information disclosed in these notes to the condensed consolidated financial statements reflected in the three and nine month periods presented are unaudited. The December 31, 2020 balance sheet included herein was derived from the audited financial statements but does not include all disclosures or notes required by GAAP for complete financial statements. Reclassifications Gross profit, which was previously reflected in the statement of operations and comprehensive loss, is no longer presented. Cost of revenue, which was presented in prior periods within gross profit, is now presented as an operating expense. The Company believes that this presentation more accurately reflects the Company’s cost of revenue and operating expenses. These reclassifications had no effect on reported net loss. Liquidity and Capital Resources During the year ended December 31, 2020, the Company generated cash flows from operations of $1,433 Beginning in the fourth quarter of 2021 and including the acquisition of PandoLogic in September 2021, the Company expects to generate positive consolidated cash flows from its operations. As a result, management believes that the Company’s existing balances of cash and cash equivalents, which totaled $72,645 as of September 30, 2021, will be sufficient to meet its anticipated cash requirements for the foreseeable future. Use of Accounting Estimates The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The principal estimates relate to the accounting recognition and presentation of revenue, allowance for doubtful accounts, purchase accounting, impairment of long-lived assets, the valuation of contingent consideration, the valuation of stock awards and stock warrants and income taxes, where applicable. There has been uncertainty and disruption in the global economy and financial markets due to the COVID-19 pandemic. The Company is not aware of any specific event or circumstance that would require an update to its estimates or assumptions or a revision of the carrying value of its assets or liabilities as of the date of filing of this Quarterly Report on Form 10-Q. These estimates and assumptions may change as new events occur and additional information is obtained. As a result, actual results could differ materially from these estimates and assumptions. Significant Customers Two individual customers accounted for 27% of the Company’s net revenues for the three months ended September 30, 2021 and no individual customer accounted for 10% of the Company’s net revenues for the nine months ended September 30, 2021. No Remaining Performance Obligations As of September 30, 2021, the aggregate amount of the transaction prices under the Company’s contracts allocated to the Company’s remaining performance obligations was $8,346 approximately 52% This aggregate amount excludes amounts allocated to remaining performance obligations under contracts that have an original duration of one year or less and variable consideration that is allocated to remaining performance obligations . Excluded based on this policy are balances related to PandoLogic representing gross purchase orders to be satisfied in less than one year. Revenues will be recognized net of costs to fulfill these orders. Significant Accounting Policies There have been no material changes in the Company’s significant accounting policies from those disclosed in its Annual Report on Form 10-K for the year ended December 31, 2020. Recently Issued Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) . The amendments under this pronouncement will change the way all leases with duration of one year or more are treated. Under this guidance, lessees will be required to capitalize virtually all leases on the balance sheet as a right-of-use asset and an associated financing lease liability or capital lease liability. The right-of-use asset represents the lessee’s right to use, or control the use of, a specified asset for the specified lease term. The lease liability represents the lessee’s obligation to make lease payments arising from the lease, measured on a discounted basis. Based on certain characteristics, leases are classified as financing leases or operating leases. Financing lease liabilities, those that contain provisions similar to capitalized leases, are amortized in the same manner as capital leases are amortized under current accounting rules, as amortization expense and interest expense in the statement of operations. Operating lease liabilities are amortized on a straight-line basis over the life of the lease as lease expense in the statement of operations. This standard will be effective for the Company beginning with the first quarter of fiscal year 2022. The Company is currently evaluating the expected impact this standard will have on its policies and procedures pertaining to its existing and future lease arrangements, its disclosure requirements and its consolidated financial statement s, but anticipates that the required recognition of a lease liability and related right-of-use asset may significantly increase both assets and liabilities recognized and reported on its balance sheet. In September 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326) which requires measurement and recognition of expected credit losses for financial assets held. This standard will be effective for the Company beginning in the first quarter of fiscal year The Company is currently evaluating the impact that this standard will have on its consolidated financial statements and related disclosures as well as the timing of adoption. In December 2019, the FASB issued ASU No. 2019-12 to simplify the accounting in ASC 740, Income Taxes and early adoption is permitted

Business Combinations

Business Combinations	9 Months Ended
	Sep. 30, 2021
Business Combinations [Abstract]
Business Combinations	NOTE 3. BUSINESS COMBINATIONS On September 14, 2021, the Company acquired 100% of PandoLogic., a company incorporated under the laws of the state of Israel, pursuant to an Agreement and Plan of Merger (the “Merger Agreement”) dated as of July 21, 2021. PandoLogic is a leading provider of intelligent hiring solutions and utilizes its proprietary platform to accelerate the time and improve the efficiency in the process for employers hiring at scale for both mass market and difficult-to-source candidates. PandoLogic’s fully autonomous recruiting platform helps employers source talent faster and more efficiently with predictive algorithms, machine learning and AI. The total purchase consideration for PandoLogic was $116,633 (the “Merger Consideration”), which consisted of upfront consideration of $58,733 in cash and $31,500 for the fair value of the Company’s 1,704,822 shares of common stock, and up to $65,000 in contingent consideration based on achieving certain earnouts tied to financial performance of PandoLogic in fiscal 2021 and 2022, which amount will be paid in a combination of cash and common stock (the “Earnout”). The total purchase consideration is preliminary and subject to net working capital adjustments that the Company expects to finalize and settle in the measurement period. The final settlement amount may vary materially as amounts are finalized and ultimately agreed to by the parties. The Company utilized a Monte Carlo simulation model to estimate the fair value of the Earnout. The fair value of the Earnout was estimated to be $30,000 as of September 14, 2021, $26,400 of which was deemed to be purchase consideration and recorded within contingent consideration current and contingent consideration non-current on the condensed consolidated balance sheet. The remaining $3,600 will be recognized as compensation expense over the earnout period in the general and administrative expenses on the condensed consolidated statement of operations and comprehensive loss. Subsequent to the acquisition date, the Company is required to reassess its estimate of the fair value of the Earnout, including certain future Earnout obligations triggered on employment status of certain PandoLogic management, and record any changes in earnings when the estimate is based on information not known as of the acquisition date (See Note 5). The Company incurred $2,161 in acquisition related expenses and has recorded them in general and administrative expenses in the condensed consolidated statement of operations and comprehensive loss The following Acquisition consideration Amount Cash consideration at closing $ 58,733 Equity consideration at closing 31,500 Contingent earnout 26,400 Total $ 116,633 The preliminary allocation of the purchase consideration to tangible and intangible assets acquired and liabilities assumed is based on estimated fair values and is as follows (in thousands): Purchase price allocation** Amount Cash $ 11,131 Accounts receivable 21,344 Prepaid and other current assets 8,986 Property and equipment 618 Intangible assets 86,000 Other assets 1,543 Total assets acquired 129,622 Accounts payable 13,183 Accrued expenses and other current liabilities 8,828 Deferred tax liability 12,073 Total liabilities assumed 34,084 Identifiable net assets acquired $ 95,538 Goodwill 21,095 Total preliminary purchase consideration $ 116,633 **The purchase price allocation has been prepared on a preliminary basis and changes to the preliminary purchase price allocation may occur as additional information concerning asset and liability valuations is finalized. The preliminary fair value estimates of the net assets acquired are based upon preliminary calculations and valuations, and those estimates and assumptions regarding certain tangible assets acquired and liabilities assumed, the valuation of intangible assets acquired, income taxes, and goodwill are subject to change as the Company obtains additional information during the measurement period (up to one year from the acquisition date). The excess of the total consideration over the tangible assets, identifiable intangible assets, and assumed liabilities is recorded as goodwill. Goodwill is primarily attributable to operational efficiencies from operating PandoLogic products on aiWARE as well as opportunities to cross-sell into our commercial enterprise customer base. Identifiable Intangible Assets The identifiable intangible assets acquired consisted of developed technology, customer relationships and tradename with estimated useful lives of 4 The fair value of the intangible assets has been estimated using a combination of the income and cost approaches. Under the income approach, the after-tax cash flows associated with the asset are discounted to present value. The key assumptions include the Company's estimates of the projected cash flows and discount rates. Under the cost approach, the replacement cost is used to estimate the value of the asset. The key assumptions include the Company's estimates of the direct and indirect costs required to replace the asset. The valuation of the intangible assets acquired from PandoLogic along with their estimated useful lives, is as follows (in thousands): Estimated Fair Value Estimated Useful Lives (in years) Customer relationships 68,000 7 Developed technology 16,000 4 Trade name 2,000 5 Total intangible assets $ 86,000 Taxes In connection with the acquisition, a deferred tax liability is established for the future consequences attributable to differences between the financial statement carrying amounts of the acquired non-goodwill intangible assets and their respective tax basis. No deferred tax asset or liability is recorded on PandoLogic goodwill, most of which is not deductible for tax purposes. No valuation allowance is recorded on the acquired PandoLogic deferred tax assets that are presented net of deferred tax liability in the preliminary purchase price allocation. The Company’s tax expense for the three and nine-month periods ended September 30, 2021 is primarily attributable to PandoLogic. Unaudited Pro Forma Results The unaudited pro forma financial information in the table below summarizes the combined results of operations for Veritone and PandoLogic, as if the companies were combined for the nine-month period ended September 30, 2021. The unaudited pro forma financial information for all periods presented included the business combination accounting effects resulting from this acquisition, including adjustments to reflect recognition of intangible asset amortization and accretion of contingent consideration. The unaudited pro forma financial information as presented below is for informational purposes only and is not necessarily indicative of the results of operations that would have been achieved if the acquisitions had taken place at the beginning of January 1, 2020. The unaudited pro forma financial information was as follows (in thousands): The Company recognized $4,311 in revenue and $1,889 of net income related to PandoLogic since the acquisition date of September 14 through September 30, 2021 in the condensed consolidated statement of operations and comprehensive loss. Three Months Ended Nine Months ended September 30, September 30, 2021 2021 Net revenue $ 35,488 $ 92,980 Loss before provision for income taxes $ (8,910 ) $ (52,199 ) Net loss $ (9,237 ) $ (53,445 ) Three Months Ended Nine Months ended September 30, September 30, 2020 2020 Net revenue $ 26,521 $ 61,809 Loss before provision for income taxes $ (8,311 ) $ (36,880 ) Net loss $ (7,974 ) $ (35,273 )

Net Loss Per Share

Net Loss Per Share	9 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Net Loss Per Share	NOTE 4. NET LOSS PER SHARE The following table presents the computation of basic and diluted net loss per share: Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 Numerator Net loss $ (11,444 ) $ (11,013 ) $ (54,726 ) $ (35,490 ) Denominator Weighted-average common shares outstanding 33,342,828 27,606,061 32,767,752 27,180,059 Less: Weighted-average shares subject to repurchase (10,160 ) (12,746 ) (14,813 ) (17,179 ) Denominator for basic and diluted net loss per share attributable to common stockholders 33,332,668 27,593,315 32,752,939 27,162,880 Basic and diluted net loss per share $ (0.34 ) $ (0.40 ) $ (1.67 ) $ (1.31 ) The Company reported net losses for all periods presented and, as such, all potentially dilutive shares of common stock would have been antidilutive for such periods. The table below presents the weighted-average securities (in common equivalent shares) outstanding during the periods presented that have been excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive: Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 Common stock options and restricted stock units 9,533,421 10,022,826 9,917,997 9,954,904 Warrants to purchase common stock 520,112 1,592,840 559,361 1,521,720 Total 10,053,533 11,615,666 10,477,358 11,476,624

Financial Instruments

Financial Instruments	9 Months Ended
	Sep. 30, 2021
Investments All Other Investments [Abstract]
Financial Instruments	NOTE 5. FINANCIAL INSTRUMENTS Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs that may be used to measure fair value. Level 1 and Level 2 are considered observable and Level 3 is considered unobservable, as follows: • Level 1—quoted prices (unadjusted) in active markets for identical assets or liabilities; • Level 2—inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or • Level 3—unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Cash and Cash Equivalents The Company’s money market funds are categorized as Level 1 within the fair value hierarchy. As of September 30, 2021, the Company’s cash and cash equivalents balances were as follows: Gross Cash and Unrealized Fair Cash Cost Losses Value Equivalents Cash $ 71,616 $ — $ 71,616 $ 71,616 Level 1: Money market funds 1,029 — 1,029 1,029 Total $ 72,645 $ — $ 72,645 $ 72,645 As of December 31, 2020, the Company’s cash and cash equivalents balances were as follows: Gross Cash and Unrealized Fair Cash Cost Losses Value Equivalents Cash $ 44,795 $ — $ 44,795 $ 44,795 Level 1: Money market funds 70,022 — 70,022 70,022 Total $ 114,817 $ — $ 114,817 $ 114,817 Contingent Consideration All of the Company’s contingent consideration liabilities are categorized as Level 3 within the fair value hierarchy. Contingent consideration was valued at the time of acquisition using the Monte Carlo simulation model. This model incorporates revenue volatility, internal rate of return, and risk free rate. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s management with the assistance of a third-party valuation specialist. As of September 30, 2021, the Company’s contingent consideration liabilities current and non-current balances were as follows: Changes in Indemnified Fair Contingent Cost Fair Value Accretion Value Consideration Level 3: Contingent consideration, current $ 19,199 $ 106 $ 2 $ 19,307 $ 19,307 Contingent consideration, non-current 8,383 150 — 8,533 8,533 Total $ 27,582 $ 256 $ 2 $ 27,840 $ 27,840 Included in the contingent consideration liabilities as of September 30, 2021 is $1,261 which relates to contingent consideration resulting from an acquisition made by Pandologic prior to execution of the Merger Agreement. As discussed in Note 8, the Company is indemnified against this contingent consideration and related accretion.

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Net	9 Months Ended
	Sep. 30, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets, Net	NOTE 6. GOODWILL AND INTANGIBLE ASSETS, NET Goodwill The carrying amount of goodwill was $27,999 as of September 30, 2021 and $6,904 December 31, 2020. Goodwill Balance at December 31, 2020 $ 6,904 Acquisition of PandoLogic 21,095 Balance at September 30, 2021 $ 27,999 Intangible Assets The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which continue to be amortized: September 30, 2021 December 31, 2020 Weighted Average Remaining Useful Life (in years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Software and technology 0.7 $ 3,582 $ (3,477 ) $ 105 $ 3,582 $ (3,357 ) $ 225 Licensed technology 0.0 500 (500 ) - 500 (375 ) 125 Developed technology 3.6 25,600 (6,087 ) 19,513 9,600 (4,480 ) 5,120 Customer relationships 6.5 77,300 (6,157 ) 71,143 9,300 (4,340 ) 4,960 Noncompete agreements 0.9 800 (640 ) 160 800 (486 ) 314 Trade names 5.0 2,000 (17 ) 1,983 - - - Total 5.8 $ 109,782 $ (16,878 ) $ 92,904 $ 23,782 $ (13,038 ) $ 10,744 The following table presents future amortization of the Company’s finite-lived intangible assets at September 30, 2021: 2021 (3 months) $ 4,671 2022 18,534 2023 17,091 2024 14,571 2025 13,409 Thereafter 24,628 Total $ 92,904

Consolidated Financial Statemen

Consolidated Financial Statements Details	9 Months Ended
	Sep. 30, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Consolidated Financial Statements Details	NOTE 7. CONSOLIDATED FINANCIAL STATEMENTS DETAILS Consolidated Balance Sheets Details Cash and cash equivalents As of September 30, 2021 and December 31, 2020, the Company had cash and cash equivalents of $72,645 and $114,817, respectively, including $56,996 and $40,052, respectively, of cash received from Commercial Managed Services clients for future payments to vendors. Accounts Receivable, Net Accounts receivable consisted of the following: As of September 30, December 31, 2021 2020 Accounts receivable — $ 18,001 $ 14,916 Accounts receivable — 40,762 1,868 58,763 16,784 Less: allowance for doubtful accounts (860 ) (118 ) Accounts receivable, net $ 57,903 $ 16,666 Property, Equipment and Improvements, Net Property, equipment and improvements, net consisted of the following: As of September 30, December 31, 2021 2020 Property and equipment $ 3,730 $ 2,365 Leasehold improvements 199 2,899 3,929 5,264 Less: accumulated depreciation (2,751 ) (2,910 ) Property, equipment and improvements, net $ 1,178 $ 2,354 During the nine months ended September 30, 2021, in connection with the sublease of its former corporate office space located in Costa Mesa, California, the Company wrote-off approximately $3,559 in property and equipment and leasehold improvements and recorded a net loss on disposal of $1,894. Depreciation expense was $95 and $349 for the three and nine months ended September 30, 2021, respectively. Depreciation expense was $264 and $776 for the three and nine months ended September 30, 2020, respectively. Accounts Payable Accounts payable consisted of the following: As of September 30, December 31, 2021 2020 Accounts payable — $ 22,738 $ 14,688 Accounts payable — 10,364 944 Total $ 33,102 $ 15,632 Consolidated Statement of Operations and Comprehensive Loss Details Revenue Revenue for the periods presented were comprised of the following: Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 Commercial Enterprise $ 21,697 $ 14,829 $ 57,460 $ 39,115 Government & Regulated Industries 958 889 2,696 1,775 Total revenue $ 22,655 $ 15,718 $ 60,156 $ 40,890 In Q3 2021, we realigned our organization to improve focus and growth into two customer groups: (1) Commercial Enterprise, which today consists of customers in the commercial sector, including our media and entertainment customers, advertising customers, content licensing customers and customers through PandoLogic that are not from government or regulated industries, and (2) Government & Regulated Industries (GRI), which today consists of customers in the government and regulated industries sectors, including our state, local and federal government, legal, compliance and energy customers. Software Products & Services consists of revenue generated from our aiWARE platform and through Pandologic’s software product solutions, any related support and maintenance services, and any related professional services associated with the deployment and or implementation of such solutions. Managed Services consists of revenues generated from our advertising agency and related services and content licensing. The table below illustrates the presentation of our revenues based on the above definitions: Three Months Ended Nine Months Ended September 30, 2021 September 30, 2021 Government & Government & Commercial Regulated Commercial Regulated Revenue Presentation Enterprises Industries Total Enterprises Industries Total Software Products & Services $ 8,069 $ 958 $ 9,027 $ 16,596 $ 2,696 $ 19,292 Managed Services Advertising 9,648 - 9,648 29,943 - 29,943 Licensing 3,980 - 3,980 10,921 - 10,921 Total Managed Services 13,628 - 13,628 40,864 - 40,864 Total Revenue $ 21,697 $ 958 $ 22,655 $ 57,460 $ 2,696 $ 60,156 (1) Software Products & Services consists of aiWARE SaaS Solutions of $4,716 and $19,292 for the three and nine months ended September 30, 2021 respectively as well PandoLogic of $4,311 for the three months September 30 Three Months Ended Nine Months Ended September 30, 2020 September 30, 2020 Government & Government & Commercial Regulated Commercial Regulated Revenue Presentation Enterprises Industries Total Enterprises Industries Total Software Products & Services $ 2,462 $ 889 $ 3,351 $ 7,686 $ 1,775 $ 9,461 Managed Services Advertising 8,764 - 8,764 21,803 - 21,803 Licensing 3,603 - 3,603 9,626 - 9,626 Total Managed Services 12,367 - 12,367 31,429 - 31,429 Total Revenue $ 14,829 $ 889 $ 15,718 $ 39,115 $ 1,775 $ 40,890 PandoLogic Revenue Recognition The Company generates revenue primarily from platform services where it provides access to digital job advertising done programmatically. Revenue is derived from AI-enabled programmatic advertising, which uses software and algorithms to match buyers and sellers of digital job advertising in a technology-driven marketplace. The Company provides the use of its solution to clients to execute digital job advertising campaigns. Campaigns are typically ordered through monthly purchase orders. The Company charges clients a fee based on the number of job searches by potential applicants through its solution during each campaign. Revenue is recognized as platform advertising services are provided during each campaign. The Company determined that it is not the principal in the purchase and sale of jobs placements Other Expense, Net Other expense, net for the periods presented was comprised of the following: Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 Interest (expense) income, net $ (3 ) $ 2 $ 4 $ 84 Change in fair value of warrant liability — — — (200 ) Other (12 ) (6 ) (41 ) 8 Other expense, net $ (15 ) $ (4 ) $ (37 ) $ (108 )

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2021
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 8. COMMITMENTS AND CONTINGENCIES Leases The Company leases facilities under operating lease arrangements expiring on various dates through fiscal year 2024. Certain of the Company’s leases contain standard rent escalation and renewal clauses. Under certain leases, the Company is required to pay operating expenses in addition to base rent. Rent expense for lease payments is recognized on a straight-line basis over the lease term. In February 2021, the Company entered into an office sublease (the “Sublease”) with a third party (the “Subtenant”), pursuant to which the Company has subleased its former office space located in Costa Mesa, California, consisting of approximately 37,875 square feet, which the Company leases pursuant to an existing lease agreement expiring in 2024 (the “Lease”). The term of the Sublease commenced in March 2021 and will continue through December 31, 2024, coterminous with the Lease. Pursuant to the Sublease, the Subtenant will pay to the Company monthly base rent, which is subject to annual rent escalations, as well as a portion of the operating expenses and taxes payable by the Company under the Lease. The Company recognized contract termination costs as a liability when it ceased using the rights conveyed under the Lease. During the nine months ended September 30, 2021, the Company recorded approximately $3,367 in charges resulting from the Sublease, consisting of $1,894 loss on disposal of property and equipment and leasehold improvements, As of September 30, 2021, future minimum lease payments were as follows: 2021 (three months) $ 589 2022 2,223 2023 1,768 2024 1,730 Total minimum payments $ 6,310 As of September 30, 2021, minimum sublease rental income to be received in the future under noncancelable subleases was approximately $3,686. The total rent expense for all operating leases, excluding the charges related to the Sublease discussed above, was $428 and $4,672 for the three and nine months ended September 30, 2021, and $748 and $2,265 for the three and nine months ended September 30, 2020, respectively. Sales Taxes The Company collects and remits sales tax in jurisdictions in which it has a physical presence or it believes nexus exists, which therefore obligates the Company to collect and remit sales tax. During the three and nine months ended September 30, 2021, the Company recorded a liability net of payments remitted to states of $ and $306, respectively, for potential exposure in several states where there is uncertainty about the point in time at which the Company established a sufficient business connection to create nexus. Other Contingencies From time to time, the Company may be involved in litigation relating to claims arising out of its operations in the normal course of business. The Company currently is not a party to any legal proceedings, the adverse outcome of which, in management’s opinion, individually or in the aggregate, would have a material adverse effect on the Company’s results of operations, financial position or cash flows. In conjunction with our acquisition of PandoLogic as outlined in Note 3, there are certain contingencies outlined in the Merger Agreement for which the Company is indemnified including, but not limited to, contingent consideration arising from a previous acquisition, and international as well as state and local tax matters. An indemnification asset has been recognized related to fair value of the contingent consideration acquired in the opening balance sheet of $1,259. As of September 30, 2021, the Company was investigating potential sales tax exposure for PandoLogic, of which potential maximum exposure is estimated to be covered and reserved for under escrow with the sellers of PandoLogic. As a result, the Company has not accrued any contingency estimates for sales tax exposure for PandoLogic as of September 30, 2021.

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit)	9 Months Ended
	Sep. 30, 2021
Equity [Abstract]
Stockholders' Equity (Deficit)	NOTE 9. STOCKHOLDERS’ EQUITY (DEFICIT) Common Stock Issuances During the nine months ended September 30, 2021 and 2020, the Company issued an aggregate of 1,084,941 and 297,490 shares of its common stock, respectively the exercise of stock options, issuance of stock awards and vesting of restricted stock units under its stock incentive plans and purchases under its Employee Stock Purchase Plan (the “ESPP”). During the nine months ended September 30, 2021, the Company issued a total of 1,704,822 shares of its common stock in connection with the acquisition of PandoLogic. During the nine months ended September 30, 2021, the Company issued a total of 252,218 shares of its common stock upon the exercise of warrants for an aggregate exercise price of $2,279 and issued an aggregate of 84,723 shares of its common stock upon exercises of warrants to purchase an aggregate of 91,833 shares of its common stock, which were effected on a net exercise basis without cash payment of the exercise price. During the nine months ended September 30, 2020, the Company issued a total of 154,311 shares of its common stock upon the exercise of warrants for an aggregate exercise price of $2,100. During the nine months ended September 30, 2021, the Company issued an aggregate of 15,828 shares of its common stock for services provided to the Company. During the nine months ended September 30, 2020, the Company issued an aggregate of 105,898 shares of common stock to the former stockholders of Machine Box, representing all of the shares previously held back from issuance by the Company with respect to the initial consideration and the additional contingent consideration. During the nine months ended September 30, 2020, the Company issued and sold an aggregate of 1,491,317 shares of its common stock pursuant to the Equity Distribution Agreement with JMP Securities (as sales agent) and received net proceeds from such sales of $5,996 after deducting expenses of $281. The Company voluntarily terminated the Equity Distribution Agreement in January 2021.

Stock Plans

Stock Plans	9 Months Ended
	Sep. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock Plans	NOTE 10. STOCK PLANS Stock-Based Compensation During the nine months ended September 30, 2021, the Company granted options to purchase an aggregate of 298,455 shares of its common stock that are subject to time-based vesting conditions. The Company valued these stock options using the Black-Scholes Merton option pricing model. The following assumptions were used to compute the grant date fair values of the stock options granted during the nine months ended September 30, 2021: Expected term (in years) 5.5 - 6.1 Expected volatility 80% - 83% Risk-free interest rate 0.6% - 1.0% Expected dividend yield — The assumptions used in calculating the fair values of purchase rights granted under the ESPP during the nine months ended September 30, 2021 are set forth in the table below: Expected term (in years) 0.5 - 2.0 Expected volatility 67% - 119% Risk-free interest rate 0.1 % Expected dividend yield — The Company’s stock-based compensation expense by type of award and by operating expense grouping are presented below: Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 Stock-based compensation expense by type of award: Restricted stock units $ 4,264 $ 2,308 $ 14,014 $ 3,203 Stock awards — 43 19 152 Machine Box contingent common stock issuances — (37 ) — (37 ) Performance-based stock options — 1,996 16,314 5,917 Stock options 791 644 2,426 4,099 Employee stock purchase plan 86 157 337 364 Common stock issued for services 131 — 381 - Total $ 5,272 $ 5,111 $ 33,491 $ 13,698 Stock-based compensation expense by operating expense grouping: Sales and marketing $ 226 $ 278 $ 1,358 $ 654 Research and development 431 172 2,016 593 General and administrative 4,615 4,661 30,117 12,451 $ 5,272 $ 5,111 $ 33,491 $ 13,698 Equity Award Activity Under Stock Plans Stock Awards The Company’s stock award activity for the nine months ended September 30, 2021 was as follows: Weighted Average Grant Shares Date Fair Value Unvested at December 31, 2020 - $ - Granted 581 $ 32.33 Forfeited - - Vested (581 ) $ 32.33 Unvested at September 30, 2021 - - All stock awards granted during the nine months ended September 30, 2021 were fully vested upon grant. As of September 30, 2021, there was no unrecognized compensation cost related to stock awards granted under the Company’s stock plans. Restricted Stock Units The Company’s restricted stock unit activity for the nine months ended September 30, 2021 was as follows: Weighted Average Grant Shares Date Fair Value Unvested at December 31, 2020 829,124 $ 11.53 Granted 448,020 $ 41.31 Forfeited (24,439 ) $ 42.92 Vested (749,374 ) $ 10.77 Unvested at September 30, 2021 503,331 $ 37.64 As of September 30, 2021, total unrecognized compensation cost related to restricted stock units was $8,033, which is expected to be recognized over a weighted average period of 1.0 year. Performance-Based Stock Options The activity during the nine months ended September 30, 2021 related to stock options that are subject to performance-based vesting conditions tied to the achievement of stock price goals by the Company was as follows: Weighted-Average Remaining Aggregate Exercise Contractual Intrinsic Options Price Term Value Outstanding at December 31, 2020 4,234,020 $ 10.55 — — Exercised (346,137 ) $ 5.78 — — Forfeited (12,552 ) $ 5.92 — — Expired (8,787 ) $ 5.28 — — Outstanding at September 30, 2021 3,866,544 $ 11.01 6.76 years $ 49,819 Exercisable at September 30, 2021 3,886,544 $ 11.01 6.76 years $ 49,819 During the first nine months of 2021, the Company achieved all of the stock price milestones applicable to substantially all of the performance-based stock options and, as a result, such performance-based stock options vested and all associated unrecognized compensation was accelerated and recognized in full as a one-time expense of $16,268 during the nine months ended September 30, 2021. The aggregate intrinsic value of the options exercised during the nine months ended September 30, 2021 was $7,665. No performance-based stock options were granted during the nine months ended September 30, 2021 and 2020, and no performance-based stock options vested during the nine months ended September 30, 2020. Stock Options The activity during the nine months ended September 30, 2021 related to all other stock options was as follows: Weighted-Average Remaining Aggregate Exercise Contractual Intrinsic Options Price Term Value Outstanding at December 31, 2020 5,400,070 $ 12.60 — — Granted 298,455 $ 28.69 — — Exercised (488,636 ) $ 9.69 — — Forfeited (169,965 ) $ 15.86 — — Expired (3,579 ) $ 6.45 — — Outstanding at September 30, 2021 5,036,345 $ 13.73 6.33 years $ 52,783 Exercisable at September 30, 2021 4,114,851 $ 13.74 5.82 years $ 41,747 The weighted average grant date fair value of stock options granted during the nine months ended September 30, 2021 and 2020 was $19.95 and $2.46 per share, respectively. The aggregate intrinsic value of the stock options exercised during the nine months ended September 30, 2021 and 2020 was $9,521 and $484 The aggregate intrinsic values in the tables above represent the difference between the fair market value of the Company’s common stock and the average option exercise price of in-the-money options, multiplied by the number of such stock options. Employee Stock Purchase Plan During the nine months ended September 30, 2021, a total of 67,068 shares of common stock were purchased under the Company’s ESPP. As of September 30, 2021, accrued employee contributions for future purchases under the ESPP totaled $157.

Presentation and Summary of S_2

Presentation and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation and Preparation	Basis of Presentation and Preparation The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial statements and the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. Such unaudited condensed consolidated financial statements and accompanying notes are based on the representations of the Company’s management, who is responsible for their integrity and objectivity. The information included in this Form 10-Q should be read in conjunction with the information included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 5, 2021. Interim results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results the Company will have for the full year ending December 31, 2021. The accompanying condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which are normal, recurring and necessary to fairly state the Company’s financial position, results of operations and cash flows. All significant intercompany transactions have been eliminated in consolidation. The financial data and the other information disclosed in these notes to the condensed consolidated financial statements reflected in the three and nine month periods presented are unaudited. The December 31, 2020 balance sheet included herein was derived from the audited financial statements but does not include all disclosures or notes required by GAAP for complete financial statements.
Reclassifications	Reclassifications Gross profit, which was previously reflected in the statement of operations and comprehensive loss, is no longer presented. Cost of revenue, which was presented in prior periods within gross profit, is now presented as an operating expense. The Company believes that this presentation more accurately reflects the Company’s cost of revenue and operating expenses. These reclassifications had no effect on reported net loss.
Liquidity and Capital Resources	Liquidity and Capital Resources During the year ended December 31, 2020, the Company generated cash flows from operations of $1,433 Beginning in the fourth quarter of 2021 and including the acquisition of PandoLogic in September 2021, the Company expects to generate positive consolidated cash flows from its operations. As a result, management believes that the Company’s existing balances of cash and cash equivalents, which totaled $72,645 as of September 30, 2021, will be sufficient to meet its anticipated cash requirements for the foreseeable future.
Use of Accounting Estimates	Use of Accounting Estimates The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The principal estimates relate to the accounting recognition and presentation of revenue, allowance for doubtful accounts, purchase accounting, impairment of long-lived assets, the valuation of contingent consideration, the valuation of stock awards and stock warrants and income taxes, where applicable. There has been uncertainty and disruption in the global economy and financial markets due to the COVID-19 pandemic. The Company is not aware of any specific event or circumstance that would require an update to its estimates or assumptions or a revision of the carrying value of its assets or liabilities as of the date of filing of this Quarterly Report on Form 10-Q. These estimates and assumptions may change as new events occur and additional information is obtained. As a result, actual results could differ materially from these estimates and assumptions.
Significant Customers	Significant Customers Two individual customers accounted for 27% of the Company’s net revenues for the three months ended September 30, 2021 and no individual customer accounted for 10% of the Company’s net revenues for the nine months ended September 30, 2021. No
Remaining Performance Obligations	Remaining Performance Obligations As of September 30, 2021, the aggregate amount of the transaction prices under the Company’s contracts allocated to the Company’s remaining performance obligations was $8,346 approximately 52% This aggregate amount excludes amounts allocated to remaining performance obligations under contracts that have an original duration of one year or less and variable consideration that is allocated to remaining performance obligations . Excluded based on this policy are balances related to PandoLogic representing gross purchase orders to be satisfied in less than one year. Revenues will be recognized net of costs to fulfill these orders.
Significant Accounting Policies	Significant Accounting Policies There have been no material changes in the Company’s significant accounting policies from those disclosed in its Annual Report on Form 10-K for the year ended December 31, 2020.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) . The amendments under this pronouncement will change the way all leases with duration of one year or more are treated. Under this guidance, lessees will be required to capitalize virtually all leases on the balance sheet as a right-of-use asset and an associated financing lease liability or capital lease liability. The right-of-use asset represents the lessee’s right to use, or control the use of, a specified asset for the specified lease term. The lease liability represents the lessee’s obligation to make lease payments arising from the lease, measured on a discounted basis. Based on certain characteristics, leases are classified as financing leases or operating leases. Financing lease liabilities, those that contain provisions similar to capitalized leases, are amortized in the same manner as capital leases are amortized under current accounting rules, as amortization expense and interest expense in the statement of operations. Operating lease liabilities are amortized on a straight-line basis over the life of the lease as lease expense in the statement of operations. This standard will be effective for the Company beginning with the first quarter of fiscal year 2022. The Company is currently evaluating the expected impact this standard will have on its policies and procedures pertaining to its existing and future lease arrangements, its disclosure requirements and its consolidated financial statement s, but anticipates that the required recognition of a lease liability and related right-of-use asset may significantly increase both assets and liabilities recognized and reported on its balance sheet. In September 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326) which requires measurement and recognition of expected credit losses for financial assets held. This standard will be effective for the Company beginning in the first quarter of fiscal year The Company is currently evaluating the impact that this standard will have on its consolidated financial statements and related disclosures as well as the timing of adoption. In December 2019, the FASB issued ASU No. 2019-12 to simplify the accounting in ASC 740, Income Taxes and early adoption is permitted

Business Combinations (Tables)

Business Combinations (Tables)	9 Months Ended
	Sep. 30, 2021
Summary of Unaudited Proforma Information	The unaudited pro forma financial information was as follows (in thousands): The Company recognized $4,311 in revenue and $1,889 of net income related to PandoLogic since the acquisition date of September 14 through September 30, 2021 in the condensed consolidated statement of operations and comprehensive loss. Three Months Ended Nine Months ended September 30, September 30, 2021 2021 Net revenue $ 35,488 $ 92,980 Loss before provision for income taxes $ (8,910 ) $ (52,199 ) Net loss $ (9,237 ) $ (53,445 ) Three Months Ended Nine Months ended September 30, September 30, 2020 2020 Net revenue $ 26,521 $ 61,809 Loss before provision for income taxes $ (8,311 ) $ (36,880 ) Net loss $ (7,974 ) $ (35,273 )
Pandologic Ltd [Member]
Summary of Preliminary Allocation of Purchase Consideration	The following Acquisition consideration Amount Cash consideration at closing $ 58,733 Equity consideration at closing 31,500 Contingent earnout 26,400 Total $ 116,633 The preliminary allocation of the purchase consideration to tangible and intangible assets acquired and liabilities assumed is based on estimated fair values and is as follows (in thousands): Purchase price allocation** Amount Cash $ 11,131 Accounts receivable 21,344 Prepaid and other current assets 8,986 Property and equipment 618 Intangible assets 86,000 Other assets 1,543 Total assets acquired 129,622 Accounts payable 13,183 Accrued expenses and other current liabilities 8,828 Deferred tax liability 12,073 Total liabilities assumed 34,084 Identifiable net assets acquired $ 95,538 Goodwill 21,095 Total preliminary purchase consideration $ 116,633
Summary of Valuation of Intangible Assets	The valuation of the intangible assets acquired from PandoLogic along with their estimated useful lives, is as follows (in thousands): Estimated Fair Value Estimated Useful Lives (in years) Customer relationships 68,000 7 Developed technology 16,000 4 Trade name 2,000 5 Total intangible assets $ 86,000

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	9 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Computation of Basic and Diluted Net Loss Per Common Share	The following table presents the computation of basic and diluted net loss per share: Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 Numerator Net loss $ (11,444 ) $ (11,013 ) $ (54,726 ) $ (35,490 ) Denominator Weighted-average common shares outstanding 33,342,828 27,606,061 32,767,752 27,180,059 Less: Weighted-average shares subject to repurchase (10,160 ) (12,746 ) (14,813 ) (17,179 ) Denominator for basic and diluted net loss per share attributable to common stockholders 33,332,668 27,593,315 32,752,939 27,162,880 Basic and diluted net loss per share $ (0.34 ) $ (0.40 ) $ (1.67 ) $ (1.31 )
Effect of Anti-dilutive Securities	The table below presents the weighted-average securities (in common equivalent shares) outstanding during the periods presented that have been excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive: Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 Common stock options and restricted stock units 9,533,421 10,022,826 9,917,997 9,954,904 Warrants to purchase common stock 520,112 1,592,840 559,361 1,521,720 Total 10,053,533 11,615,666 10,477,358 11,476,624

Financial Instruments (Tables)

Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2021
Investments All Other Investments [Abstract]
Schedule of Cash and Cash Equivalents	As of September 30, 2021, the Company’s cash and cash equivalents balances were as follows: Gross Cash and Unrealized Fair Cash Cost Losses Value Equivalents Cash $ 71,616 $ — $ 71,616 $ 71,616 Level 1: Money market funds 1,029 — 1,029 1,029 Total $ 72,645 $ — $ 72,645 $ 72,645 As of December 31, 2020, the Company’s cash and cash equivalents balances were as follows: Gross Cash and Unrealized Fair Cash Cost Losses Value Equivalents Cash $ 44,795 $ — $ 44,795 $ 44,795 Level 1: Money market funds 70,022 — 70,022 70,022 Total $ 114,817 $ — $ 114,817 $ 114,817
Schedule of Contingent Consideration Liabilities Current and Non-current Balances	As of September 30, 2021, the Company’s contingent consideration liabilities current and non-current balances were as follows: Changes in Indemnified Fair Contingent Cost Fair Value Accretion Value Consideration Level 3: Contingent consideration, current $ 19,199 $ 106 $ 2 $ 19,307 $ 19,307 Contingent consideration, non-current 8,383 150 — 8,533 8,533 Total $ 27,582 $ 256 $ 2 $ 27,840 $ 27,840

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Net (Tables)	9 Months Ended
	Sep. 30, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
Schedule of Carrying Amount of Goodwill	The carrying amount of goodwill was $27,999 as of September 30, 2021 and $6,904 December 31, 2020. Goodwill Balance at December 31, 2020 $ 6,904 Acquisition of PandoLogic 21,095 Balance at September 30, 2021 $ 27,999
Summary of Finite-Lived Intangible Assets Resulting from Business Acquisitions and Other Purchases	The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which continue to be amortized: September 30, 2021 December 31, 2020 Weighted Average Remaining Useful Life (in years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Software and technology 0.7 $ 3,582 $ (3,477 ) $ 105 $ 3,582 $ (3,357 ) $ 225 Licensed technology 0.0 500 (500 ) - 500 (375 ) 125 Developed technology 3.6 25,600 (6,087 ) 19,513 9,600 (4,480 ) 5,120 Customer relationships 6.5 77,300 (6,157 ) 71,143 9,300 (4,340 ) 4,960 Noncompete agreements 0.9 800 (640 ) 160 800 (486 ) 314 Trade names 5.0 2,000 (17 ) 1,983 - - - Total 5.8 $ 109,782 $ (16,878 ) $ 92,904 $ 23,782 $ (13,038 ) $ 10,744
Summary of Future Amortization of Finite-Lived Intangible Assets	The following table presents future amortization of the Company’s finite-lived intangible assets at September 30, 2021: 2021 (3 months) $ 4,671 2022 18,534 2023 17,091 2024 14,571 2025 13,409 Thereafter 24,628 Total $ 92,904

Consolidated Financial Statem_2

Consolidated Financial Statements Details (Tables)	9 Months Ended
	Sep. 30, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Summary of Accounts Receivable, Net	Accounts receivable consisted of the following: As of September 30, December 31, 2021 2020 Accounts receivable — $ 18,001 $ 14,916 Accounts receivable — 40,762 1,868 58,763 16,784 Less: allowance for doubtful accounts (860 ) (118 ) Accounts receivable, net $ 57,903 $ 16,666
Summary of Property Equipment and Improvements, Net	Property, equipment and improvements, net consisted of the following: As of September 30, December 31, 2021 2020 Property and equipment $ 3,730 $ 2,365 Leasehold improvements 199 2,899 3,929 5,264 Less: accumulated depreciation (2,751 ) (2,910 ) Property, equipment and improvements, net $ 1,178 $ 2,354
Summary of Accounts Payable	Accounts payable consisted of the following: As of September 30, December 31, 2021 2020 Accounts payable — $ 22,738 $ 14,688 Accounts payable — 10,364 944 Total $ 33,102 $ 15,632
Summary of Revenue	Revenue for the periods presented were comprised of the following: Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 Commercial Enterprise $ 21,697 $ 14,829 $ 57,460 $ 39,115 Government & Regulated Industries 958 889 2,696 1,775 Total revenue $ 22,655 $ 15,718 $ 60,156 $ 40,890
Summary of Presentation of Revenues	The table below illustrates the presentation of our revenues based on the above definitions: Three Months Ended Nine Months Ended September 30, 2021 September 30, 2021 Government & Government & Commercial Regulated Commercial Regulated Revenue Presentation Enterprises Industries Total Enterprises Industries Total Software Products & Services $ 8,069 $ 958 $ 9,027 $ 16,596 $ 2,696 $ 19,292 Managed Services Advertising 9,648 - 9,648 29,943 - 29,943 Licensing 3,980 - 3,980 10,921 - 10,921 Total Managed Services 13,628 - 13,628 40,864 - 40,864 Total Revenue $ 21,697 $ 958 $ 22,655 $ 57,460 $ 2,696 $ 60,156 (1) Software Products & Services consists of aiWARE SaaS Solutions of $4,716 and $19,292 for the three and nine months ended September 30, 2021 respectively as well PandoLogic of $4,311 for the three months September 30 Three Months Ended Nine Months Ended September 30, 2020 September 30, 2020 Government & Government & Commercial Regulated Commercial Regulated Revenue Presentation Enterprises Industries Total Enterprises Industries Total Software Products & Services $ 2,462 $ 889 $ 3,351 $ 7,686 $ 1,775 $ 9,461 Managed Services Advertising 8,764 - 8,764 21,803 - 21,803 Licensing 3,603 - 3,603 9,626 - 9,626 Total Managed Services 12,367 - 12,367 31,429 - 31,429 Total Revenue $ 14,829 $ 889 $ 15,718 $ 39,115 $ 1,775 $ 40,890
Schedule of Other Expense, Net	Other expense, net for the periods presented was comprised of the following: Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 Interest (expense) income, net $ (3 ) $ 2 $ 4 $ 84 Change in fair value of warrant liability — — — (200 ) Other (12 ) (6 ) (41 ) 8 Other expense, net $ (15 ) $ (4 ) $ (37 ) $ (108 )

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2021
Commitments And Contingencies Disclosure [Abstract]
Summary of Future Minimum Lease Payments	As of September 30, 2021, future minimum lease payments were as follows: 2021 (three months) $ 589 2022 2,223 2023 1,768 2024 1,730 Total minimum payments $ 6,310

Stock Plans (Tables)

Stock Plans (Tables)	9 Months Ended
	Sep. 30, 2021
Schedule of Stock-based Compensation Expense	The Company’s stock-based compensation expense by type of award and by operating expense grouping are presented below: Three Months Ended Nine Months Ended September 30, September 30, 2021 2020 2021 2020 Stock-based compensation expense by type of award: Restricted stock units $ 4,264 $ 2,308 $ 14,014 $ 3,203 Stock awards — 43 19 152 Machine Box contingent common stock issuances — (37 ) — (37 ) Performance-based stock options — 1,996 16,314 5,917 Stock options 791 644 2,426 4,099 Employee stock purchase plan 86 157 337 364 Common stock issued for services 131 — 381 - Total $ 5,272 $ 5,111 $ 33,491 $ 13,698 Stock-based compensation expense by operating expense grouping: Sales and marketing $ 226 $ 278 $ 1,358 $ 654 Research and development 431 172 2,016 593 General and administrative 4,615 4,661 30,117 12,451 $ 5,272 $ 5,111 $ 33,491 $ 13,698
Schedule of Stock Award Activity	The Company’s stock award activity for the nine months ended September 30, 2021 was as follows: Weighted Average Grant Shares Date Fair Value Unvested at December 31, 2020 - $ - Granted 581 $ 32.33 Forfeited - - Vested (581 ) $ 32.33 Unvested at September 30, 2021 - -
Schedule of Restricted Stock Unit Activity	The Company’s restricted stock unit activity for the nine months ended September 30, 2021 was as follows: Weighted Average Grant Shares Date Fair Value Unvested at December 31, 2020 829,124 $ 11.53 Granted 448,020 $ 41.31 Forfeited (24,439 ) $ 42.92 Vested (749,374 ) $ 10.77 Unvested at September 30, 2021 503,331 $ 37.64
Schedule of Stock Option Activity	The activity during the nine months ended September 30, 2021 related to all other stock options was as follows: Weighted-Average Remaining Aggregate Exercise Contractual Intrinsic Options Price Term Value Outstanding at December 31, 2020 5,400,070 $ 12.60 — — Granted 298,455 $ 28.69 — — Exercised (488,636 ) $ 9.69 — — Forfeited (169,965 ) $ 15.86 — — Expired (3,579 ) $ 6.45 — — Outstanding at September 30, 2021 5,036,345 $ 13.73 6.33 years $ 52,783 Exercisable at September 30, 2021 4,114,851 $ 13.74 5.82 years $ 41,747
Employee Stock Purchase Plan [Member]
Summary of Fair Value Assumptions of Stock Purchase Plan	The assumptions used in calculating the fair values of purchase rights granted under the ESPP during the nine months ended September 30, 2021 are set forth in the table below: Expected term (in years) 0.5 - 2.0 Expected volatility 67% - 119% Risk-free interest rate 0.1 % Expected dividend yield —
Stock Options [Member]
Schedule of Fair Value Assumptions	The following assumptions were used to compute the grant date fair values of the stock options granted during the nine months ended September 30, 2021: Expected term (in years) 5.5 - 6.1 Expected volatility 80% - 83% Risk-free interest rate 0.6% - 1.0% Expected dividend yield —
Performance-based Stock Options [Member]
Schedule of Stock Option Activity	The activity during the nine months ended September 30, 2021 related to stock options that are subject to performance-based vesting conditions tied to the achievement of stock price goals by the Company was as follows: Weighted-Average Remaining Aggregate Exercise Contractual Intrinsic Options Price Term Value Outstanding at December 31, 2020 4,234,020 $ 10.55 — — Exercised (346,137 ) $ 5.78 — — Forfeited (12,552 ) $ 5.92 — — Expired (8,787 ) $ 5.28 — — Outstanding at September 30, 2021 3,866,544 $ 11.01 6.76 years $ 49,819 Exercisable at September 30, 2021 3,886,544 $ 11.01 6.76 years $ 49,819

Presentation and Summary of S_3

Presentation and Summary of Significant Accounting Policies - Additional Information (Details) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021USD ($)Customer	Sep. 30, 2020USD ($)Customer	Sep. 30, 2021USD ($)Customer	Sep. 30, 2020USD ($)Customer	Dec. 31, 2020USD ($)Customer
Significant Accounting Policies [Line Items]
Positive (negative) cash flows from operations			$ (3,528)		$ 1,433
Net loss	$ 11,444	$ 11,013	54,726	$ 35,490	47,876
Accumulated deficit	335,091		335,091		280,365
Net proceeds from sales of common stock from the period					59,771
Proceeds from issuances of stock under employee stock plans, net			7,127	356
Net proceeds from sales of common stock				6,517
Proceeds from the exercise of warrants			2,279	$ 2,100
Cash and cash equivalents	72,645		72,645		$ 114,817
Transaction price remaining performance obligations	$ 8,346		$ 8,346
Transaction price remaining performance obligations percentage	52.00%		52.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Significant Accounting Policies [Line Items]
Number of major customers | Customer	2	0	0	0
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Minimum [Member]
Significant Accounting Policies [Line Items]
Concentration risk percentage	27.00%	10.00%	10.00%	10.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Commercial Enterprise [Member]
Significant Accounting Policies [Line Items]
Number of major customers | Customer			3		2
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Commercial Enterprise [Member] | Minimum [Member]
Significant Accounting Policies [Line Items]
Concentration risk percentage			10.00%		10.00%
Equity Distribution Agreement [Member]
Significant Accounting Policies [Line Items]
Net proceeds from sales of common stock					$ 5,986

Presentation and Summary of S_4

Presentation and Summary of Significant Accounting Policies - Additional Information (Details 1)	Sep. 30, 2021
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-10-01
Significant Accounting Policies [Line Items]
Expected Recognition of revenue over remaining contract terms	12 months

Business Combinations - Additio

Business Combinations - Additional Information (Detail) - USD ($)	Sep. 14, 2021	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Business Acquisition [Line Items]
Revenue			$ 22,655,000	$ 15,718,000	$ 60,156,000	$ 40,890,000
Net loss			(11,444,000)	$ (11,013,000)	$ (54,726,000)	$ (35,490,000)	$ (47,876,000)
Pandologic Ltd [Member]
Business Acquisition [Line Items]
Total consideration	$ 116,633,000
Equity consideration at closing	31,500,000
Contingent earnout	30,000,000
Business combination, measurement period					up to one year from the acquisition date
Deferred tax assets		$ 0	0		$ 0
Deferred tax liabilities	12,073,000	0	0		0
Deferred tax assets, valuation allowance		0	$ 0		0
Revenue		4,311,000
Net loss		$ 1,889,000
Pandologic Ltd [Member] | General and Administrative Expense [Member]
Business Acquisition [Line Items]
Acquisition related expenses					$ 2,161,000
Pandologic Ltd [Member] | Recognized in Compensation Expense Within General and Administrative Expense [Member]
Business Acquisition [Line Items]
Contingent earnout	3,600,000
Pandologic Ltd [Member] | Maximum [Member]
Business Acquisition [Line Items]
Estimated useful lives					7 years
Pandologic Ltd [Member] | Minimum [Member]
Business Acquisition [Line Items]
Estimated useful lives					4 years
Pandologic Ltd [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Merger consideration equity interest issued number of shares					1,704,822
Pandologic Ltd [Member] | Contingent Consideration
Business Acquisition [Line Items]
Contingent earnout	$ 26,400,000
Merger Agreement [Member] | Pandologic Ltd [Member]
Business Acquisition [Line Items]
Business acquisition, effective date of acquisition	Sep. 14, 2021
Business acquisition, percentage of ownership interests acquired	100.00%
Business acquisition, name of acquired entity	PandoLogic.
Business acquisition, date of acquisition agreement	Jul. 21, 2021
Total consideration	$ 116,633,000
Merger consideration upfront payment in cash	58,733,000
Merger Agreement [Member] | Pandologic Ltd [Member] | Maximum [Member]
Business Acquisition [Line Items]
Merger, earnout consideration payable	65,000,000
Merger Agreement [Member] | Pandologic Ltd [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Equity consideration at closing	$ 31,500,000
Merger consideration equity interest issued number of shares	1,704,822

Business Combinations - Summary

Business Combinations - Summary of Fair Value of Purchase Price Consideration (Details) - Pandologic Ltd [Member] $ in Thousands	Sep. 14, 2021USD ($)
Business Acquisition [Line Items]
Cash consideration at closing	$ 58,733
Equity consideration at closing	31,500
Contingent earnout	30,000
Total	116,633
Contingent Consideration
Business Acquisition [Line Items]
Contingent earnout	$ 26,400

Business Combinations - Summa_2

Business Combinations - Summary of Preliminary Allocation of Purchase Consideration (Details) - USD ($)	Sep. 30, 2021	Sep. 14, 2021	Dec. 31, 2020
Business Acquisition [Line Items]
Goodwill	$ 27,999,000		$ 6,904,000
Pandologic Ltd [Member]
Business Acquisition [Line Items]
Cash		$ 11,131,000
Accounts receivable		21,344,000
Prepaid and other current assets		8,986,000
Property and equipment		618,000
Intangible assets		86,000,000
Other assets		1,543,000
Total assets acquired		129,622,000
Accounts payable		13,183,000
Accrued expenses and other current liabilities		8,828,000
Deferred tax liability	$ 0	12,073,000
Total liabilities assumed		34,084,000
Identifiable net assets acquired		95,538,000
Goodwill		21,095,000
Total preliminary purchase consideration		$ 116,633,000

Business Combinations - Summa_3

Business Combinations - Summary of Valuation of Intangible Assets (Details) - Pandologic Ltd [Member] $ in Thousands	Sep. 14, 2021USD ($)
Business Acquisition [Line Items]
Total intangible assets	$ 86,000
Customer Relationships [Member]
Business Acquisition [Line Items]
Total intangible assets	$ 68,000
Estimated useful lives	7 years
Developed Technology [Member]
Business Acquisition [Line Items]
Total intangible assets	$ 16,000
Estimated useful lives	4 years
Trade Name [Member]
Business Acquisition [Line Items]
Total intangible assets	$ 2,000
Estimated useful lives	5 years

Business Combinations - Summa_4

Business Combinations - Summary of Unaudited Proforma Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Business Combinations [Abstract]
Net revenue	$ 35,488	$ 26,521	$ 92,980	$ 61,809
Loss before provision for income taxes	(8,910)	(8,311)	(52,199)	(36,880)
Net loss	$ (9,237)	$ (7,974)	$ (53,445)	$ (35,273)

Net Income Loss Per Share - Com

Net Income Loss Per Share - Computation of Basic and Diluted Net Loss Per Common Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Numerator
Net loss	$ (11,444)	$ (11,013)	$ (54,726)	$ (35,490)	$ (47,876)
Denominator
Weighted-average common shares outstanding	33,342,828	27,606,061	32,767,752	27,180,059
Less: Weighted-average shares subject to repurchase	(10,160)	(12,746)	(14,813)	(17,179)
Denominator for basic and diluted net loss per share attributable to common stockholders	33,332,668	27,593,315	32,752,939	27,162,880
Basic and diluted net loss per share	$ (0.34)	$ (0.40)	$ (1.67)	$ (1.31)

Net Income Loss Per Share - Eff

Net Income Loss Per Share - Effect of Anti-dilutive Securities (Detail) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	10,053,533	11,615,666	10,477,358	11,476,624
Employee Stock Option and Restricted Stock Units [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	9,533,421	10,022,826	9,917,997	9,954,904
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	520,112	1,592,840	559,361	1,521,720

Financial Instruments - Schedul

Financial Instruments - Schedule of Cash and Cash Equivalents (Detail) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Schedule Of Available For Sale Securities [Line Items]
Total Cash and Debt Securities	$ 72,645	$ 114,817
Total Fair Value, Cash and Debt Securities	72,645	114,817
Cash and cash equivalents	72,645	114,817
Cash [Member]
Schedule Of Available For Sale Securities [Line Items]
Cash and cash equivalents	71,616	44,795
Fair Value, Cash	71,616	44,795
Level 1 [Member] | Money Market Funds [Member]
Schedule Of Available For Sale Securities [Line Items]
Cash and cash equivalents	1,029	70,022
Cash and cash equivalents gross before unrealized losses	1,029	70,022
Fair Value, Cash	$ 1,029	$ 70,022

Financial Instruments - Sched_2

Financial Instruments - Schedule of Contingent Consideration Liabilities Current and Non-current Balances (Details) - Level 3 [Member] $ in Thousands	Sep. 30, 2021USD ($)
Contingent Consideration Liabilities [Line Items]
Cost	$ 27,582
Changes in Fair Value	256
Indemnified Accretion	2
Fair Value	27,840
Contingent Consideration	27,840
Contingent Consideration, Current [Member]
Contingent Consideration Liabilities [Line Items]
Cost	19,199
Changes in Fair Value	106
Indemnified Accretion	2
Fair Value	19,307
Contingent Consideration	19,307
Contingent Consideration, Noncurrent [Member]
Contingent Consideration Liabilities [Line Items]
Cost	8,383
Changes in Fair Value	150
Fair Value	8,533
Contingent Consideration	$ 8,533

Financial Instruments - Additio

Financial Instruments - Additional Information (Details) $ in Thousands	Sep. 30, 2021USD ($)
Pandologic Ltd [Member]
Contingent Consideration Liabilities [Line Items]
Contingent Consideration	$ 1,261

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets, Net - Additional Information (Detail) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Carrying amount of goodwill	$ 27,999	$ 6,904

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets, Net - Schedule of Carrying Amount of Goodwill (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2021USD ($)
Impairment Of Intangible Assets Excluding Goodwill [Abstract]
Beginning balance	$ 6,904
Acquisition of PandoLogic	21,095
Ending balance	$ 27,999

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets, Net - Summary of Finite-Lived Intangible Assets Resulting from Business Acquisitions and Other Purchases (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	5 years 9 months 18 days
Gross Carrying Amount	$ 109,782	$ 23,782
Accumulated Amortization	(16,878)	(13,038)
Net Carrying Amount	$ 92,904	10,744
Software and Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	8 months 12 days
Gross Carrying Amount	$ 3,582	3,582
Accumulated Amortization	(3,477)	(3,357)
Net Carrying Amount	$ 105	225
Licensed Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	0 years
Gross Carrying Amount	$ 500	500
Accumulated Amortization	$ (500)	(375)
Net Carrying Amount		125
Developed Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	3 years 7 months 6 days
Gross Carrying Amount	$ 25,600	9,600
Accumulated Amortization	(6,087)	(4,480)
Net Carrying Amount	$ 19,513	5,120
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	6 years 6 months
Gross Carrying Amount	$ 77,300	9,300
Accumulated Amortization	(6,157)	(4,340)
Net Carrying Amount	$ 71,143	4,960
Noncompete Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	10 months 24 days
Gross Carrying Amount	$ 800	800
Accumulated Amortization	(640)	(486)
Net Carrying Amount	$ 160	$ 314
Trade Name [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	5 years
Gross Carrying Amount	$ 2,000
Accumulated Amortization	(17)
Net Carrying Amount	$ 1,983

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets, Net - Summary of Future Amortization of Finite-Lived Intangible Assets (Detail) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Finite Lived Intangible Assets Future Amortization Expense [Abstract]
2021 (3 months)	$ 4,671
2022	18,534
2023	17,091
2024	14,571
2025	13,409
Thereafter	24,628
Net Carrying Amount	$ 92,904	$ 10,744

Consolidated Financial Statem_3

Consolidated Financial Statements Details - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents	$ 72,645		$ 72,645		$ 114,817
Write-off of property and equipment and leasehold improvements			3,559
Loss on disposal			1,894
Depreciation Expense	95	$ 264	349	$ 776
Commercial Managed Services Clients [Member]
Condensed Financial Statements, Captions [Line Items]
Cash received	$ 56,996		$ 56,996		$ 40,052

Consolidated Financial Statem_4

Consolidated Financial Statements Details - Summary of Accounts Receivable,Net (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Accounts receivable, gross	$ 58,763	$ 16,784
Less: allowance for doubtful accounts	(860)	(118)
Accounts receivable, net	57,903	16,666
Commercial Managed Services [Member]
Accounts receivable, gross	18,001	14,916
Other [Member]
Accounts receivable, gross	$ 40,762	$ 1,868

Consolidated Financial Statem_5

Consolidated Financial Statements Details - Summary of Property Equipment and Improvements, Net (Detail) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Property Plant And Equipment [Abstract]
Property and equipment	$ 3,730	$ 2,365
Leasehold improvements	199	2,899
Property, equipment and improvements, gross	3,929	5,264
Less: accumulated depreciation	(2,751)	(2,910)
Property, equipment and improvements, net	$ 1,178	$ 2,354

Consolidated Financial Statem_6

Consolidated Financial Statements Details - Accounts Payable (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Statement Of Financial Position [Abstract]
Accounts payable — Commercial Managed Services	$ 22,738	$ 14,688
Accounts payable — Other	10,364	944
Total	$ 33,102	$ 15,632

Consolidated Financial Statem_7

Consolidated Financial Statements Details - Summary of Revenue (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Segment Reporting Revenue Reconciling Item [Line Items]
Total revenue	$ 22,655	$ 15,718	$ 60,156	$ 40,890
Commercial Enterprise [Member]
Segment Reporting Revenue Reconciling Item [Line Items]
Total revenue	21,697	14,829	57,460	39,115
Government and Regulated Industries [Member]
Segment Reporting Revenue Reconciling Item [Line Items]
Total revenue	$ 958	$ 889	$ 2,696	$ 1,775

Consolidated Financial Statem_8

Consolidated Financial Statements Details - Summary of Presentation of Revenues (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenue Presentation
Revenue	$ 22,655	$ 15,718	$ 60,156	$ 40,890
Commercial Enterprises [Member]
Revenue Presentation
Revenue	21,697	14,829	57,460	39,115
Government and Regulated Industries [Member]
Revenue Presentation
Revenue	958	889	2,696	1,775
Software Products and Services [Member]
Revenue Presentation
Revenue	9,027	3,351	19,292	9,461
Software Products and Services [Member] | Commercial Enterprises [Member]
Revenue Presentation
Revenue	8,069	2,462	16,596	7,686
Software Products and Services [Member] | Government and Regulated Industries [Member]
Revenue Presentation
Revenue	958	889	2,696	1,775
Advertising [Member]
Revenue Presentation
Revenue	9,648	8,764	29,943	21,803
Advertising [Member] | Commercial Enterprises [Member]
Revenue Presentation
Revenue	9,648	8,764	29,943	21,803
Licensing [Member]
Revenue Presentation
Revenue	3,980	3,603	10,921	9,626
Licensing [Member] | Commercial Enterprises [Member]
Revenue Presentation
Revenue	3,980	3,603	10,921	9,626
Total Managed Services [Member]
Revenue Presentation
Revenue	13,628	12,367	40,864	31,429
Total Managed Services [Member] | Commercial Enterprises [Member]
Revenue Presentation
Revenue	$ 13,628	$ 12,367	$ 40,864	$ 31,429

Consolidated Financial Statem_9

Consolidated Financial Statements Details - Summary of Presentation of Revenues (Parenthetical) (Detail) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenue		$ 22,655	$ 15,718	$ 60,156	$ 40,890
Pandologic Ltd [Member]
Revenue	$ 4,311
Software Products or Services Consists of aiWARE SaaS Solutions [Member]
Revenue		4,716		19,292
Software Products and Services [Member]
Revenue		9,027	$ 3,351	$ 19,292	$ 9,461
Software Products and Services [Member] | Pandologic Ltd [Member]
Revenue		$ 4,311

Consolidated Financial State_10

Consolidated Financial Statements Details - Schedule of Other Expense, Net (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Other Income And Expenses [Abstract]
Interest (expense) income, net	$ (3)	$ 2	$ 4	$ 84
Change in fair value of warrant liability				(200)
Other	(12)	(6)	(41)	8
Other expense, net	$ (15)	$ (4)	$ (37)	$ (108)

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended
	Feb. 28, 2021ft²	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)	Sep. 14, 2021USD ($)
Other Commitments [Line Items]
Loss on disposal of property and equipment and leasehold improvements				$ (1,894)	$ (102)
Loss on sublease				1,211
Minimum sublease rental income to be received in the future under noncancelable subleases		$ 3,686		3,686
Rent expense		428	$ 748	4,672	$ 2,265
Liability net of payments remitted to states for potential exposure		$ 22		306
PandoLogic [Member]
Other Commitments [Line Items]
Indemnification asset related to fair value of contingent consideration acquired						$ 1,259
Office Sublease [Member]
Other Commitments [Line Items]
Area of Office Space Subleased | ft²	37,875
Lease Expiration Date	Dec. 31, 2024
Sublease charges				3,367
Loss on disposal of property and equipment and leasehold improvements				(1,894)
Loss on sublease				1,211
Initial direct costs				$ 262

Commitments and Contingencies_2

Commitments and Contingencies - Summary of Future Minimum Lease Payments (Detail) - Building Lease Agreement [Member] $ in Thousands	Sep. 30, 2021USD ($)
Other Commitments [Line Items]
2021 (three months)	$ 589
2022	2,223
2023	1,768
2024	1,730
Total minimum payments	$ 6,310

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit) - Additional Information (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Class Of Stock [Line Items]
Net proceeds from stock issuance		$ 6,517
Exercise of warrants	$ 2,279	2,100
JMP Securities [Member]
Class Of Stock [Line Items]
Net proceeds from stock issuance		$ 5,996
Common Stock [Member]
Class Of Stock [Line Items]
Shares issued to outside service provider, shares	15,828
Common stock shares issued		1,491,317
Exercise of warrants	$ 2,279	$ 2,100
Exercise of warrants issued, shares for cash consideration	252,218	154,311
Aggregate exercise of warrants issued, shares	84,723
Issued warrants to purchase shares upon exercises	91,833
Common Stock [Member] | Pandologic Ltd [Member]
Class Of Stock [Line Items]
Business acquisition, shares issued or issuable	1,704,822
Common Stock [Member] | Machine Box [Member]
Class Of Stock [Line Items]
Business acquisition, shares issued or issuable		105,898
Common Stock [Member] | JMP Securities [Member]
Class Of Stock [Line Items]
Common stock shares issued		1,491,317
Stock issuance costs		$ 281
Common Stock and Employee Stock Purchase Plan [Member]
Class Of Stock [Line Items]
Shares issued in connection with stock option exercise	1,084,941	297,490

Stock Plans - Additional Inform

Stock Plans - Additional Information (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Employee Stock Purchase Plan [Member]
Class Of Stock [Line Items]
Common stock were purchased under ESPP	67,068
Accrued employee contributions	$ 157,000
Timebased Stock Option [Member]
Class Of Stock [Line Items]
Options granted	298,455
Stock Awards [Member]
Class Of Stock [Line Items]
Unrecognized cost of share-based compensation awards	$ 0
Restricted Stock Units [Member]
Class Of Stock [Line Items]
Unrecognized cost of share-based compensation awards	$ 8,033,000
Cost of share-based compensation awards, recognition period	1 year
Performance-based Stock Options [Member]
Class Of Stock [Line Items]
Total grant date fair value of stock options granted	$ 0	$ 0
Total grant date fair value of stock options vested		0
Unrecognized compensation expense related to stock options	16,268,000
Aggregate intrinsic value of the options exercised	$ 7,665,000	0
Stock Options [Member]
Class Of Stock [Line Items]
Options granted	298,455
Cost of share-based compensation awards, recognition period	2 years 11 months 19 days
Total grant date fair value of stock options vested	$ 1,797,000	4,659,000
Unrecognized compensation expense related to stock options	7,502,000
Aggregate intrinsic value of the options exercised	$ 9,521,000	$ 484,000
Weighted Average Grant Date Fair Value, Granted	$ 19.95	$ 2.46

Stock Plans - Schedule of Fair

Stock Plans - Schedule of Fair Value Assumptions (Detail) - Stock Options [Member]	9 Months Ended
	Sep. 30, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected volatility, minimum	80.00%
Expected volatility, maximum	83.00%
Risk-free interest rate, minimum	0.60%
Risk-free interest rate, maximum	1.00%
Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (in years)	5 years 6 months
Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (in years)	6 years 1 month 6 days

Stock Plans - Summary of Fair V

Stock Plans - Summary of Fair Value Assumptions of Stock Purchase Plan (Detail) - Employee Stock Purchase Plan [Member]	9 Months Ended
	Sep. 30, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected volatility, minimum	67.00%
Expected volatility, maximum	119.00%
Risk-free interest rate	0.10%
Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (in years)	6 months
Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (in years)	2 years

Stock Plans - Schedule of Stock

Stock Plans - Schedule of Stock-based Compensation Expense (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 5,272	$ 5,111	$ 33,491	$ 13,698
Sales and Marketing [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	226	278	1,358	654
Research and Development [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	431	172	2,016	593
General and Administrative [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	4,615	4,661	30,117	12,451
Restricted Stock Units [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	4,264	2,308	14,014	3,203
Stock Awards [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense		43	19	152
Machine Box Contingent Common Stock Issuances [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense		(37)		(37)
Performance-based Stock Options [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense		1,996	16,314	5,917
Stock Options [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	791	644	2,426	4,099
Common Stock Issued for Services [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	131		381
Employee Stock Purchase Plan [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 86	$ 157	$ 337	$ 364

Stock Plans - Schedule of Sto_2

Stock Plans - Schedule of Stock Award Activity (Detail) - Stock Awards [Member]	9 Months Ended
	Sep. 30, 2021$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares, Granted | shares	581
Shares, Vested | shares	(581)
Weighted Average Grant Date Fair Value, Granted | $ / shares	$ 32.33
Weighted Average Grant Date Fair Value, Vested | $ / shares	$ 32.33

Stock Plans - Schedule of Restr

Stock Plans - Schedule of Restricted Stock Unit Activity (Detail) - Restricted Stock Units [Member]	9 Months Ended
	Sep. 30, 2021$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares, Unvested, Beginning Balance | shares	829,124
Shares, Granted | shares	448,020
Shares, Forfeited | shares	(24,439)
Shares, Vested | shares	(749,374)
Shares, Unvested, Ending Balance | shares	503,331
Weighted Average Grant Date Fair Value, Unvested, Beginning Balance | $ / shares	$ 11.53
Weighted Average Grant Date Fair Value, Granted | $ / shares	41.31
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	42.92
Weighted Average Grant Date Fair Value, Vested | $ / shares	10.77
Weighted Average Grant Date Fair Value, Unvested, Ending Balance | $ / shares	$ 37.64

Stock Plans - Schedule of Perfo

Stock Plans - Schedule of Performance-Based Stock Options Activity (Detail) - Performance-based Stock Options [Member] $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2021USD ($)$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options, Outstanding, Beginning Balance | shares	4,234,020
Options Exercised | shares	(346,137)
Options Forfeited | shares	(12,552)
Options Expired | shares	(8,787)
Options, Outstanding, Ending Balance | shares	3,866,544
Options Exercisable at March 31, 2021 | shares	3,886,544
Weighted-Average Exercise Price, Outstanding, Beginning Balance | $ / shares	$ 10.55
Weighted-Average Exercise Price, Options Exercised | $ / shares	5.78
Weighted-Average Exercise Price, Options Forfeited | $ / shares	5.92
Weighted-Average Exercise Price, Options Expired | $ / shares	5.28
Weighted-Average Exercise Price, Outstanding, Ending Balance | $ / shares	11.01
Weighted-Average Exercise Price, Exercisable | $ / shares	$ 11.01
Weighted-Average Remaining Contractual Term, Outstanding	6 years 9 months 3 days
Weighted-Average Remaining Exercisable	6 years 9 months 3 days
Weighted-Average Aggregate Intrinsic Value | $	$ 49,819
Weighted-Average Aggregate Intrinsic Value, Exercisable | $	$ 49,819

Stock Plans - Schedule of Sto_3

Stock Plans - Schedule of Stock Option Activity (Detail) - Stock Options [Member] $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2021USD ($)$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options, Outstanding, Beginning Balance | shares	5,400,070
Options Granted | shares	298,455
Options Exercised | shares	(488,636)
Options Forfeited | shares	(169,965)
Options Expired | shares	(3,579)
Options, Outstanding, Ending Balance | shares	5,036,345
Options Exercisable at March 31, 2021 | shares	4,114,851
Weighted-Average Exercise Price, Outstanding, Beginning Balance | $ / shares	$ 12.60
Weighted-Average Exercise Price, Options Granted | $ / shares	28.69
Weighted-Average Exercise Price, Options Exercised | $ / shares	9.69
Weighted-Average Exercise Price, Options Forfeited | $ / shares	15.86
Weighted-Average Exercise Price, Options Expired | $ / shares	6.45
Weighted-Average Exercise Price, Outstanding, Ending Balance | $ / shares	13.73
Weighted-Average Exercise Price, Exercisable | $ / shares	$ 13.74
Weighted-Average Remaining Contractual Term, Outstanding	6 years 3 months 29 days
Weighted-Average Remaining Exercisable	5 years 9 months 25 days
Weighted-Average Aggregate Intrinsic Value | $	$ 52,783
Weighted-Average Aggregate Intrinsic Value, Exercisable | $	$ 41,747